Harmony Biosciences Holdings (Nasdaq: HRMY) reported record sales for its narcolepsy treatment WAKIX in 2024 and projected stronger revenue for 2025, as the company advances several clinical trials including a non-THC cannabidiol treatment for a rare genetic disorder. The company said Tuesday that WAKIX generated $201.3 million in revenue during …
Marijuana consumers across the nation are under siege. Here’s how NORML is fighting back. The post Cannabis Freedoms Are Under Attack appeared first on NORML.
Hemp goods maker LFTD Partners (OTCQB: LIFD) announced Tuesday it entered into letters of intent for four separate acquisitions to expand into the regulated cannabis market in Illinois. The company plans to buy Illinois cannabis licenses, lease manufacturing space in Skokie, purchase industrial buildings in Rockford and invest in retail …
High Tide Inc. (Nasdaq: HITI) (TSXV: HITI) halted its planned acquisition of German cannabis company Purecan GmbH, the Canadian retailer announced Tuesday, just weeks after initially unveiling the deal. The company is now looking at different ways to enter the German medical cannabis market after reconsidering the deal structure during …